相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Levetiracetam for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
P. Stathis et al.
MOVEMENT DISORDERS (2011)
Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary Movements
Xuebing Cao et al.
JOURNAL OF NEUROSCIENCE (2010)
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat
Manon Lebel et al.
NEUROBIOLOGY OF DISEASE (2010)
Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
Emanuela Santini et al.
PLOS ONE (2010)
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia
M. Angela Cenci et al.
RECENT ADVANCES IN PARKINSONS DISEASE: BASIC RESEARCH (2010)
Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease
Olivier Berton et al.
BIOLOGICAL PSYCHIATRY (2009)
Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications
Yan Xu et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2009)
Dopamine receptors and L-dopa-induced dyskinesia
Amandine Berthet et al.
PARKINSONISM & RELATED DISORDERS (2009)
PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels
Chien-Hsing Lee et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The cannabinoid system in Parkinson's disease: Multiple targets to motor effects
Stella M. Papa
EXPERIMENTAL NEUROLOGY (2008)
Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements
Li Liang et al.
JOURNAL OF NEUROSCIENCE (2008)
Treatment of levodopa-induced motor complications
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2008)
Molecular mechanisms underlying levodopa-induced dyskinesia
Paolo Calabresi et al.
MOVEMENT DISORDERS (2008)
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
NATURE REVIEWS NEUROSCIENCE (2008)
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
Jenny E. Westin et al.
BIOLOGICAL PSYCHIATRY (2007)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia
KE Lyons et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
TA Zesiewicz et al.
MOVEMENT DISORDERS (2005)
The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease
B Tousi et al.
PARKINSONISM & RELATED DISORDERS (2005)
Increased D-1 dopamine receptor signaling in levodopa-induced dyskinesia
I Aubert et al.
ANNALS OF NEUROLOGY (2005)
Levedracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
E Bezard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Levetiracetam interferes with the L-dopa priming process in MPTP-lesioned drug-naive marmosets
MP Hill et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates
SM Papa et al.
ANNALS OF NEUROLOGY (2004)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease
CR Gerfen
NEUROSCIENTIST (2003)
Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease
PK Tekumalla et al.
BIOLOGICAL PSYCHIATRY (2001)
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
E Bezard et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial
JJ Cereghino et al.
NEUROLOGY (2000)
分享论文
